home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
TRACON’s TRC105 Receives FDA Fast Track Designation
TRACON’s TRC105 Receives FDA Fast Track Designation
Post navigation
Previous Post
Previous
Nextech Invest Portfolio Company Blueprint Medicines Raises US$ 147 million in Upsized IPO on NASDAQ
Next Post
Next
MacroGenics Presents Updated Data from Phase 1 Study of Margetuximab at ASCO Annual Meeting 2015